Literature DB >> 31786409

Motoric cognitive risk syndrome is associated with processing speed and executive function, but not delayed free recall memory: The Korean frailty and aging cohort study (KFACS).

Hayoung Shim1, Miji Kim2, Chang Won Won3.   

Abstract

BACKGROUND: The motoric cognitive risk (MCR) syndrome, characterized by slow gait and cognitive complaints, is a high risk for transitioning to dementia. However, little is known regarding the cognitive profile among individuals with MCR. This study was performed to examine the association of MCR with cognitive functional domains.
METHODS: We analyzed 2881 community-dwelling older adults aged 70-84 years (52 % women, mean age: 75.9 years) from the nationwide Korean Frailty and Aging Cohort Study. MCR was defined as the presence of subjective cognitive complaints and slow gait ≥ 1.0 standard deviations below age- and sex-specific means. Cognitive function was assessed using the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet and the Frontal Assessment Battery.
RESULTS: A total of 231 participants met MCR criteria (prevalence = 8.02 %; 95 % confidence interval [CI]: 7.07-9.08 %). The prevalence of MCR did not increase with advancing age: 70-74 years, 8.90 %; 75-79 years, 7.06 %; and 80-84 years, 8.04 %; moreover, there were no sex-related differences. After adjusting for various confounders, MCR was associated with decline in global cognitive function, attention, processing speed and executive function (all P < 0.05). In particular, MCR was significantly associated with impairments in processing speed (odds ratio [OR]: 1.89, 95 % CI: 1.16-3.07) and executive function (OR: 1.94, 95 % CI: 1.28-2.93) (P > 0.05).
CONCLUSIONS: MCR was associated with deficits in global cognition, processing speed, and executive function, but not delayed free recall memory. Individuals with MCR had an increased risk of poor cognitive profile related to brain frontal and prefrontal function.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cognitive impairment; Gait speed; KFACS; Memory; Older adults; Subjective cognitive complaints

Mesh:

Year:  2019        PMID: 31786409     DOI: 10.1016/j.archger.2019.103990

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

1.  Cognitive Motor Dual Task Costs in Older Adults with Motoric Cognitive Risk Syndrome.

Authors:  N Ward; A Menta; S Peach; S A White; S Jaffe; C Kowaleski; K Grandjean da Costa; J Verghese; K F Reid
Journal:  J Frailty Aging       Date:  2021

2.  NUTRITIONAL RISK STATUS, DIETARY INTAKE AND COGNITIVE PERFORMANCE IN OLDER ADULTS WITH MOTORIC COGNITIVE RISK SYNDROME.

Authors:  S A White; N Ward; J Verghese; A F Kramer; K Grandjean da Costa; C K Liu; C Kowaleski; K F Reid
Journal:  JAR Life       Date:  2020

3.  Motoric Cognitive Risk Syndrome Using Three-Item Recall Test and Its Associations with Fall-Related Outcomes: The Korean Frailty and Aging Cohort Study.

Authors:  Hayoung Shim; Miji Kim; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2020-05-12       Impact factor: 3.390

4.  Associations between post-stroke motor and cognitive function: a cross-sectional study.

Authors:  Marte Stine Einstad; Ingvild Saltvedt; Stian Lydersen; Marie H Ursin; Ragnhild Munthe-Kaas; Hege Ihle-Hansen; Anne-Brita Knapskog; Torunn Askim; Mona K Beyer; Halvor Næss; Yngve M Seljeseth; Hanne Ellekjær; Pernille Thingstad
Journal:  BMC Geriatr       Date:  2021-02-05       Impact factor: 3.921

Review 5.  Motoric Cognitive Risk Syndrome: Symptoms, Pathology, Diagnosis, and Recovery.

Authors:  Ke Xiang; Yin Liu; Li Sun
Journal:  Front Aging Neurosci       Date:  2022-02-02       Impact factor: 5.750

6.  Functional capacity and dual-task cost in the institutionalized older adults, both affected and unaffected by mild cognitive impairment.

Authors:  Marek Zak; Szymon Krupnik; Waldemar Brola; Dorota Rebak; Tomasz Sikorski; Frederic Dutheil; Jaroslaw Andrychowski; Daniel Courteix
Journal:  Eur Rev Aging Phys Act       Date:  2021-07-12       Impact factor: 3.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.